DGAP-Adhoc: PAION DECIDE TO PUT ON HOLD THE LAUNCH OF REMIFENTANIL IN GERMANY

| Source: EQS Group AG EQS Group AG 

PAION AG  / Key word(s): Research Update

06.03.2013 08:05

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

PAION DECIDE TO PUT ON HOLD THE LAUNCH OF REMIFENTANIL IN GERMANY 

Aachen (Germany), 06 March 2013 - PAION AG (ISIN DE000A0B65S3; Frankfurt
Stock Exchange, General Standard: PA8), a biopharmaceutical company,
announced today that due to a significant unexpected price erosion in the
German Remifentanil market over the last six months, PAION has decided to
put on hold the launch of generic Remifentanil into the German market.
Together with its manufacturer PAION will further evaluate the prevailing
market conditions before taking a final decision on Remifentanil. PAION
remains committed to its vision 'PAIONeer in Anaesthesia' and maintains its
plan to launch suitable companion products to prepare for the market entry
of Remimazolam in Europe.
Today's decision contributes to secure sufficient funds until the end of Q1
2015.

###

Contact
Ralf Penner
Director Investor Relations / Public Relations
PAION AG
Martinstrasse 10-12
52062 Aachen - Germany
Phone: +49 241 4453-152
E-mail: r.penner@paion.com
www.paion.com

Disclaimer:
This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG's management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such
forward-looking statements. Considering the risks, uncertainties and other
factors involved, recipients should not rely unreasonably upon these
forward-looking statements. PAION AG has no obligation to periodically
update any such forward-looking statements to reflect future events or
developments.


06.03.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      PAION AG
              Martinstr. 10-12
              52062 Aachen
              Germany
Phone:        +49 (0)241-4453-0
Fax:          +49 (0)241-4453-100
E-mail:       info@paion.com
Internet:     www.paion.com
ISIN:         DE000A0B65S3
WKN:          A0B65S
Listed:       Regulierter Markt in Frankfurt (General Standard);
              Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
              Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------